TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06372405

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive reappraisal
Description: Cognitive reappraisal is a psychotherapeutic strategy utilized to regulate emotions by reinterpreting the meaning of stimuli. Participants will receive instructions on generating and implementing cognitive reappraisal (distancing and reframing) in both misophonic and non-misophonic contexts and will be practicing it within psychotherapeutic sessions. The program consists of four weekly online psychotherapeutic sessions: the first session will be a 90-minute group session, followed by three individual sessions, each lasting 30 minutes.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Schultz Autogenic Training
Description: Schultz Autogenic Training is a relaxation technique aimed at promoting relaxation and reducing physiological arousal. It consists of six exercises focusing on sensations of heaviness, warmth, heartbeat, breathing, abdominal warmth, and coolness of the forehead. The program consists of four weekly online psychotherapeutic sessions: the first session will be a 90-minute group session, followed by three individual sessions, each lasting 30 minutes.
Study: NCT05261581

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Erector Spinae Plane Block
Description: Erector spinae block (ESB) is an ultrasound-guided interfascial plane block. The local anesthetic is injected using ultrasound guidance superficial to transverse process and deep to erector spinae muscle group

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: NSAID
Description: Non-steroidal anti-inflammatory drugs (NSAIDs) are medicines that are widely used to relieve pain, reduce inflammation.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NSAID
Description: Non-steroidal anti-inflammatory drugs (NSAIDs) are medicines that are widely used to relieve pain, reduce inflammation.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Home Exercise Programme
Description: Home exercise programme will include some stretches that aid in pain relief by helping take stress off the low back and hips, core stabilization exercises and postural exercises.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home Exercise Programme
Description: Home exercise programme will include some stretches that aid in pain relief by helping take stress off the low back and hips, core stabilization exercises and postural exercises.
Study: NCT04976933

Intervention type: BEHAVIORAL
Intervention: mHealth adherence app
Description: The mHealth app is designed to remind caregivers to give medication in the outpatient setting, track adherence, and capture real time barriers to adherence if medication is missed.
Study: NCT04415996

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: HVLA L3/4
Description: The participant will be lateral decubitus and the investigator will locate the third lumbar vertebra. Then with one hand the investigator will contact the interspinous space underlying L3 and with the other hand he will take the top leg into flexion until the investigator feels tension in L3/L4 joint. Then he puls the tables´s arm until felling tension in the region to be manipulated. Afterwards the investigator will globally rotate the participant in the horizontal plane and will approach to the L3/L4 joint. With one arm the investigator will contact the deltopectoral groove and with the other one will contact the external iliac fossa. Finally, the investigator will compress and rotate the pelvis and will apply an impulse in a rapid rotation, without losing the parameters with a body drop allowed by the flexion of the knees and the contraction of the large pectorals.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham
Description: The participant will be in lateral decubitus and the top leg and knee will be flexed until the foot reaches the popliteal region of the other leg. There won't be applied any tension in no structure. This intervention will be applied during 20 seconds each side.
Study: NCT04619381

Intervention type: BEHAVIORAL
Intervention: CORONARY ARTERY DISEASE AND CLOPIDOGREL: PATIENT SURVEY
Description: Survey is a non-standardized assessment of demographics, medication compliance and reasons for non- compliance.
Study: NCT06611280

Intervention type: OTHER
Intervention: No Interventions
Description: No delivered intervention.

Intervention type: OTHER
Intervention: No Interventions
Description: No delivered intervention.
Study: NCT06632821

Intervention type: OTHER
Intervention: No intervention will be used.
Description: University students' health literacy, physical activity, back pain and posture habits will be evaluated.
Study: NCT06632912

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: 2 doses of vaccine Quadrivalent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha)
Description: Two doses of the experimental vaccine were injected into the deltoid muscle of the upper arm according to the immunization schedule at 0 and 6 months.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: 3 doses of vaccine Quadrivalent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha)
Description: Three doses of the experimental vaccine were injected into the deltoid muscle of the upper arm according to the immunization schedule at 0, 2, and 6 months.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: 3 doses of vaccine Quadrivalent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha)
Description: Three doses of the experimental vaccine were injected into the deltoid muscle of the upper arm according to the immunization schedule at 0, 2, and 6 months.
Study: NCT06632535

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Chiropractic care
Description: Chiropractic treatment will involve a personalized treatment plan within the context of a general care protocol administered by a chiropractor at the Osher Clinical Center for Integrative Health. The treatment plan will be customized to the patient's clinical needs following the current evidence and clinical practice guidelines.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Group medical visits
Description: Participants will simultaneously enroll in virtual group medical visits with group discussion, practice based learning, and curricular themes pertaining to chronic pain management, healthy aging, and pillars of lifestyle medicine.
Study: NCT06257095

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stepped-care social and mental health engagement
Description: Each student will be matched to an older adult and the students will make one call o the older adult which lasts upto 1 hour each week for 8 weeks. Ending each call, the student will assess symptoms of depression anxiety through questionnaires. If the participant responds yes on two consecutive calls to any of these questions, they will be asked if they would like to receive a call from the University of Texas Health Science Center Trauma and Resilience Center to discuss free counseling services.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: APS Usual care
Description: Participants will receive a phone call for data collection. Then they will be offered to receive an abbreviated version of the stepped-care social and mental health engagement intervention, lasting only 6-weeks with the option to continue calls if agreeable between the student and older adult.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: APS Usual care
Description: Participants will receive a phone call for data collection. Then they will be offered to receive an abbreviated version of the stepped-care social and mental health engagement intervention, lasting only 6-weeks with the option to continue calls if agreeable between the student and older adult.
Study: NCT05734248

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Facial filler injection
Description: Hyaluronic acid will be injected on the cheek, based on the aesthetic evaluation of the face.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Facial filler injection
Description: Hyaluronic acid will be injected on the cheek, based on the aesthetic evaluation of the face.
Study: NCT06416046

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Gemini laser
Description: Photobiomodulation (810 + 980 nm, 15s/point, 11.8J/cm²) to evaluate healing and pain relief in recurrent aphthous stomatitis. A 0.7mm intraoral tip will be used - spot 0.38cm2 on the extent of the lesion.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Examination and follow-up until the lesion heals spontaneously. The laser will not be activated.
Study: NCT05620537

Intervention type: OTHER
Intervention: observation
Description: There are no interventions.
Study: NCT05912270

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Orchestra in Class
Description: See arm/group descriptions

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Orchestra in Class
Description: See arm/group descriptions

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Orchestra in Class
Description: See arm/group descriptions
Study: NCT04841603

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Mindshift CBT
Description: A tablet with the Mindshift CBT app installed. Mindshift CBT is a free, evidence based app developed by Anxiety Canada, designed to help users reduce symptoms of anxiety and distress.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as Usual
Description: Treatment as usual. A tablet identical to the intervention group, but without the Mindshift CBT app is available for patients to use during their inpatient stay.
Study: NCT06161285

Intervention type: OTHER
Group type: OTHER
Intervention: Sampling
Description: Single-time sampling of respiratory virus-infected children

Intervention type: OTHER
Group type: OTHER
Intervention: Sampling
Description: Single-time sampling of respiratory virus-infected children
Study: NCT05488509

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cannabis
Description: Participants will inhale vapor from cannabis containing either 20mg THC or 40mg THC.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cannabis
Description: Participants will inhale vapor from cannabis containing either 20mg THC or 40mg THC.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will inhale vapor from a placebo product.
Study: NCT05672485

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: SPECT/CT imaging with 99mTc-P137 nuclide probe
Description: inject the tracer 99mTc-P137 to subjects and perform SPECT/CT scans
Study: NCT05494658

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: BCAA
Description: 600ml drink which contains 18g BCAA was consumed by patients 2-4h before surgery.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: water
Description: 600ml water was consumed by patients 2-4h before suegery.
Study: NCT05484336

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Glucose as reference food
Description: Thirteen healthy, with BMI between 18 and 29.9 kg/m2 (male: 3, female:10) after 10-14h fast, consumed 50g glucose diluted in 250ml, tested two times, in different visits, within 5-10min. Fingertip capillary blood glucose samples were taken at baseline, 15, 30, 45, 60, 90 and 120min.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Glucose as reference food
Description: Thirteen healthy, with BMI between 18 and 29.9 kg/m2 (male: 3, female:10) after 10-14h fast, consumed 50g glucose diluted in 250ml, tested two times, in different visits, within 5-10min. Fingertip capillary blood glucose samples were taken at baseline, 15, 30, 45, 60, 90 and 120min.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Glucose as reference food
Description: Thirteen healthy, with BMI between 18 and 29.9 kg/m2 (male: 3, female:10) after 10-14h fast, consumed 50g glucose diluted in 250ml, tested two times, in different visits, within 5-10min. Fingertip capillary blood glucose samples were taken at baseline, 15, 30, 45, 60, 90 and 120min.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Glucose as reference food
Description: Thirteen healthy, with BMI between 18 and 29.9 kg/m2 (male: 3, female:10) after 10-14h fast, consumed 50g glucose diluted in 250ml, tested two times, in different visits, within 5-10min. Fingertip capillary blood glucose samples were taken at baseline, 15, 30, 45, 60, 90 and 120min.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Beverage containing 4g spirulina
Description: Thirteen healthy, with BMI between 18 and 29.9 kg/m2 (male: 3, female:10) after 10-14h fast, consumed 50g glucose and 4g spirulina diluted in 250ml, tested once, within 5-10min. Fingertip capillary blood glucose samples were taken at baseline, 15, 30, 45, 60, 90 and 120min.
Study: NCT05740917

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XZB-0004
Description: XZB-0004 orally Twice daily of every 28-day cycle
Study: NCT05481424

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Biodynamic
Description: This will be a nine-hour lighting scheme that includes three modes: morning, noon, and afternoon. It mimics natural lighting by providing blue-enriched bright lighting in the morning and yellowish dimmed lighting in the afternoon. The lighting scheme is designed to satisfy the visual lighting needs of office workers while maintaining a robust circadian clock.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Biodynamic
Description: This will be a nine-hour lighting scheme that includes three modes: morning, noon, and afternoon. It mimics natural lighting by providing blue-enriched bright lighting in the morning and yellowish dimmed lighting in the afternoon. The lighting scheme is designed to satisfy the visual lighting needs of office workers while maintaining a robust circadian clock.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Active Placebo
Description: We will include an active placebo condition that will be a whole-day lighting scheme with constant color and brightness during working hours. This condition is designed to serve to requirements: (1) to simulate a conventional, well-lit office lighting in compliance with the WELL standard V1 recommendations for circadian lighting design, and (2) to provide an Equivalent Melanopic Lux (EML) equal to the geometric average of EML delivered by the Biodynamic condition. Participants will receive a similar dose of lighting under both the Placebo and Biodynamic conditions; however, the time factor is ignored in the Placebo, and hence the method of delivery is different (constant versus dynamic).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Active Placebo
Description: We will include an active placebo condition that will be a whole-day lighting scheme with constant color and brightness during working hours. This condition is designed to serve to requirements: (1) to simulate a conventional, well-lit office lighting in compliance with the WELL standard V1 recommendations for circadian lighting design, and (2) to provide an Equivalent Melanopic Lux (EML) equal to the geometric average of EML delivered by the Biodynamic condition. Participants will receive a similar dose of lighting under both the Placebo and Biodynamic conditions; however, the time factor is ignored in the Placebo, and hence the method of delivery is different (constant versus dynamic).
Study: NCT05484336

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Beverage containing 4g spirulina
Description: Thirteen healthy, with BMI between 18 and 29.9 kg/m2 (male: 3, female:10) after 10-14h fast, consumed 50g glucose and 4g spirulina diluted in 250ml, tested once, within 5-10min. Fingertip capillary blood glucose samples were taken at baseline, 15, 30, 45, 60, 90 and 120min.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Beverage containing 4g spirulina
Description: Thirteen healthy, with BMI between 18 and 29.9 kg/m2 (male: 3, female:10) after 10-14h fast, consumed 50g glucose and 4g spirulina diluted in 250ml, tested once, within 5-10min. Fingertip capillary blood glucose samples were taken at baseline, 15, 30, 45, 60, 90 and 120min.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Beverage containing 4g spirulina
Description: Thirteen healthy, with BMI between 18 and 29.9 kg/m2 (male: 3, female:10) after 10-14h fast, consumed 50g glucose and 4g spirulina diluted in 250ml, tested once, within 5-10min. Fingertip capillary blood glucose samples were taken at baseline, 15, 30, 45, 60, 90 and 120min.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Beverage containing 6g spirulina
Description: Thirteen healthy, with BMI between 18 and 29.9 kg/m2 (male: 3, female:10) after 10-14h fast, consumed 50g glucose and 6g spirulina diluted in 250ml, tested once, within 5-10min. Fingertip capillary blood glucose samples were taken at baseline, 15, 30, 45, 60, 90 and 120min.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Beverage containing 6g spirulina
Description: Thirteen healthy, with BMI between 18 and 29.9 kg/m2 (male: 3, female:10) after 10-14h fast, consumed 50g glucose and 6g spirulina diluted in 250ml, tested once, within 5-10min. Fingertip capillary blood glucose samples were taken at baseline, 15, 30, 45, 60, 90 and 120min.
Study: NCT06373224

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Flush
Description: After identifying the lymph node or lesion to be biopsied on ultrasound, using the endobronchial ultrasound scope, two 60mL syringes of cold saline will be inserted, through the biopsy channel of the endobronchial ultrasound scope, directly onto the bronchial wall where the biopsies are to be performed. The saline will then be sucked out of the airway using the endobronchial ultrasound scope.
Study: NCT03256539

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sleep intervention
Description: Behavioral sleep intervention program
Study: NCT05138965

Intervention type: PROCEDURE
Intervention: the mCP with alginates dressing
Description: The method is to use gauzes folded onto the RVF wound surface to compact the deep wound so as to solid and durable,when the gauzes surface will be covered by alginates dressing.

Intervention type: PROCEDURE
Intervention: only alginates dressing
Description: Only alginates dressing will be placed above the RVF wound without any pressure.
Study: NCT05314699

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: resistance-aerobic exercise, RA
Description: Participants conduct 5-min warm up, 13-min resistance exercise, 12-min aerobic exercise, and 5-min cool down.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: aerobic-resistance exercise, AR
Description: Participants conduct warm up for 5-min, aerobic exercise for 12-min, resistance exercise for 13-min, and 5-min cold down.
Study: NCT06356649

Intervention type: PROCEDURE
Intervention: extubation
Description: Complications after extubation

Intervention type: PROCEDURE
Intervention: extubation
Description: Complications after extubation
Study: NCT06033495

Intervention type: DEVICE
Intervention: Coronary sinus reduction stent
Description: Percutaneous stent implantation to reduce the dimension of the coronary sinus
Study: NCT05371249

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vonoprazan-based triple therapy
Description: vonoprazan 20mg+amoxicillin 1000 mg + clarithromycin 500 mg twice daily for seven days

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Extended sequential therapy
Description: Lansoprazole 30mg + amoxicillin 1000mg twice daily for 7 days, followed by lansoprazole 30mg + clarithromycin 500mg + metronidazole 500mg twice daily for 7 days
Study: NCT04498585

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: VR Stimulation
Description: Participants in the intervention group will be provided with 30 minutes of relaxing, 360-degree virtual reality stimulation and corresponding sounds, three times a day (morning, midday, evening) everyday during their stay in the ICU, up to a maximum of 14 days.
Study: NCT05010291

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard of Care (SOC) text message reminder to attend clinic appointment
Description: SOC one-way text message reminding recipient of care to either 1) attend a scheduled clinic appointment or 2) visit the clinic after a missed appointment.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Loss aversion framed text message reminder to attend clinic appointment
Description: Loss aversion framed one-way text message reminding recipient of care to either 1) attend a scheduled clinic appointment or 2) visit the clinic after a missed appointment.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Social norms framed text message reminder to attend clinic appointment
Description: Social norms framed one-way text message reminding recipient of care to either 1) attend a scheduled clinic appointment or 2) visit the clinic after a missed appointment.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Altruism framed text message reminder to attend clinic appointment
Description: Altruism framed one-way text message reminding recipient of care to either 1) attend a scheduled clinic appointment or 2) visit the clinic after a missed appointment.
Study: NCT05352269

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: XBI-302
Description: Fecal Microbiota Transplantation Capsules

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: XBI-302
Description: Fecal Microbiota Transplantation Capsules

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: XBI-302
Description: Fecal Microbiota Transplantation Capsules

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: XBI-302
Description: Fecal Microbiota Transplantation Capsules

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: XBI-302 Placebo
Description: XBI-302 Placebo

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: XBI-302 Placebo
Description: XBI-302 Placebo

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: XBI-302 Placebo
Description: XBI-302 Placebo

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: XBI-302 Placebo
Description: XBI-302 Placebo
Study: NCT03256539

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo intervention
Description: Quasi-desensitization intervention for insomnia (which does not include any of the active components of CBT-I but implemented in the same frequency and duration)